Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction

Annals of Surgical Oncology

Volumn 10, Issue 8, 2003, Pages 954-960

  Räsänen, Jari V ^a   Sihvo, Eero I T ^a   Knuuti, M Juhani ^b   Minn, Heikki R I ^b   Luostarinen, Markku E S ^c   Laippala, Pekka ^d   Viljanen, Tapio ^b   Salo, Jarmo A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Adenocarcinoma; Esophagogastric junction; Esophagus; Positron emission tomography; Staging

Indexed keywords

ABDOMINAL AORTA; ACCURACY; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CARCINOMATOSIS; CELIAC ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; ENDOSCOPIC ECHOGRAPHY; ESOPHAGEAL ADENOCARCINOMA; HUMAN; INTERMETHOD COMPARISON; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; ADENOCARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ESOPHAGUS TUMOR; PATHOLOGY; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1542304377     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2003.12.002     Document Type: Article

References (40)

1. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-3.
2. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
3. Sihvo EI, Salminen JT, Rämö OJ, Salo JA. The epidemiology of oesophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroenterol 2000;35:1082-6.
4. Masurin VS, Ryndin VD, Efimov ON, Allahverdjian AS. Surgery of localized cardioesophageal cancer. Semin Surg Oncol 1992;8: 33-6.
5. Rahamim J, Cham CW. Oesophagogastrectomy for carcinoma of the oesophagus and cardia. Br J Surg 1993;80:1305-9.
6. Steup WH, De Leyn P, Deneffe G, Van Raemdonck D, Coosemans W, Lerut T. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification. J Thonic Cardiovasc Surg 1996;111:85-94, discussion 94-5.
7. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234:360-7, discussion 368-9.
8. Ajani JA, Komaki R, Putnam JB, et al. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 2001;92:279-86.
9. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-7.
10. Lew JI, Gooding WE, Ribeiro U Jr, Safatle-Ribeiro AV, Posner MC. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg 2001; 136:737-42, discussion 743.
11. Stein HJ, Feith M, Mueller J, Werner M, Siewert JR. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 2000;232:733-42.
12. Kelly S, Harris KM, Berry E, et al. A systematic review of the staging performance of endoscopie ultrasound in gastro-oesophageal carcinoma. Gut 2001;49:534-9.
13. Richards DG, Brown TH, Manson JM. Endoscopie ultrasound in the staging of tumours of the oesophagus and gastro-oesophageal junction. Ann R Coll Surg Engl 2000;82:311-7.
14. Vickers J. Role of endoscopie ultrasound in the preoperative assessment of patients with oesophageal cancer. Ann R Coll Surg Engl 1998;80:233-9.
15. Salminen JT, Färkkila MA, Rämö OJ, et al. Endoscopic ultrasonography in the preoperative staging of adenocarcinoma of the distal oesophagus and oesophagogastric junction. Scand J Gastroenterol 1999;34:1178-82.
16. Maerz LL, Deveney CW, Lopez RR, McConnell DB. Role of computed tomographic scans in the staging of esophageal and proximal gastric malignancies. Am J Surg 1993;165:558-60.
17. Botet JF, Lightdale CJ, Zauber AG, et al. Preoperative staging of gastric cancer: comparison of endoscopie US and dynamic CT. Radiology 1991;181:426-32.
18. Reed CE, Mishra G, Sahai AV, Hoffman BJ, Hawes RH. Esophageal cancer staging: improved accuracy by endoscopie ultrasound of celiac lymph nodes. Ann Thorac Surg 1999;67:319-21, discussion 322.
19. Collard JM. Role of videoassisted surgery in the treatment of oesophageal cancer. Ann Chir Gynaecol 1995;84:209-14.
20. Luketich JD, Schauer P, Urso K, et al. Minimally invasive surgical biopsy confirms PET findings in esophageal cancer. Surg Endosc 1997;11:1213-5.
21. Romijn MG, van Overhagen H, Spillenaar Bilgen EJ, Ijzermans JN, Tilanus HW, Lameris JS. Laparoscopy and laparoscopic ultrasonography in staging of oesophageal and cardial carcinoma. Br J Surg 1998;85:1010-2.
22. Pauwels EK, McCready VR, Stoot JH, van Deurzen DF. The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med 1998;25:277-305.
23. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-48, discussion 649-50.
24. 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997;168:417-24.
25. Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 1998;78:521-7.
26. 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol 1999;72:525-9.
27. Kim K, Park SJ, Kim BT, Lee KS, Shim YM. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thoruc Surg 2001;71:290-4.
28. Rankin SC, Taylor H, Cook GJ, Mason R. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 1998;53:659-65.
29. Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999;86:1638-48.
30. Lerut T, Flamen P, Ectors N, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 2000: 232:743-52.
31. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors. 5th ed. New York: Wiley, 1997:54-8.
32. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-8.
33. Fleiss JL, ed. Statistical Methods for Rates and Proportions. 2nd ed. New York: Wiley, 1981.
34. Dwyer AJ. Matchmaking and McNemar in the comparison of diagnostic modalities. Radiology 1991;178:328-30.
35. Ell C, May A, Gossner L, et al. Endoscopie mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-7.
36. Lonneux M, Borbath I, Bol A, et al. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction. Eur J Nucl Med 1999;26:591-8.
37. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-10.
38. Vickers J, Alderson D. Influence of luminal obstruction on oesophageal cancer staging using endoscopie ultrasonography. Br J Surg 1998;85:999-1001.
39. Luketich JD, Schauer P, Landreneau R, et al. Minimally invasive surgical staging is superior to endoscopie ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 1997;114:817-21, discussion 821-3.
40. Luketich JD, Friedman DM, Weigel TL, et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 1999;68:1133-6, discussion 1136-7.